227 related articles for article (PubMed ID: 15185533)
21. [Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
Milchev N; Terzhumanov R; Grozdanov G; Krumov G
Akush Ginekol (Sofiia); 1992; 31(2):42-3. PubMed ID: 1342561
[No Abstract] [Full Text] [Related]
22. A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.
Jespersen J; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Sidelmann JJ; Skouby SO
Contraception; 2005 Aug; 72(2):98-104. PubMed ID: 16022847
[TBL] [Abstract][Full Text] [Related]
23. Exercise-induced fibrin formation is enhanced in women using third-generation oral contraceptives.
Walter B; Weiss C; Dorsch M; Bärtsch P
J Thromb Haemost; 2006 Apr; 4(4):898-9. PubMed ID: 16634763
[No Abstract] [Full Text] [Related]
24. Mircette: a novel oral contraceptive. Introduction.
Speroff L
Am J Obstet Gynecol; 1998 Jul; 179(1):S1. PubMed ID: 9704811
[No Abstract] [Full Text] [Related]
25. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Christie T
J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
[No Abstract] [Full Text] [Related]
26. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
Urdinola J
Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
[No Abstract] [Full Text] [Related]
27. [A combiphasic oral contraceptive containing ethinylestradiol and desogestrel].
Poulsen HK
Ugeskr Laeger; 1995 Aug; 157(32):4473-5. PubMed ID: 7483033
[No Abstract] [Full Text] [Related]
28. Clinical experience with a low-dose contraceptive agent. European studies.
Haspels AA
J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703
[TBL] [Abstract][Full Text] [Related]
29. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
[TBL] [Abstract][Full Text] [Related]
30. Sexual function in first-time contraceptive ring and contraceptive patch users.
Gracia CR; Sammel MD; Charlesworth S; Lin H; Barnhart KT; Creinin MD
Fertil Steril; 2010 Jan; 93(1):21-8. PubMed ID: 18976753
[TBL] [Abstract][Full Text] [Related]
31. [Oxytetral and Lindynette].
Ravnbak K
Ugeskr Laeger; 2006 Sep; 168(39):3335; author reply 3335. PubMed ID: 17036420
[No Abstract] [Full Text] [Related]
32. A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.
Winkler UH; Daume E; Sudik R; Oberhoff C; Bier U; Hallmann C; Andreas JO; Schindler AE
Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):145-54. PubMed ID: 10574640
[TBL] [Abstract][Full Text] [Related]
33. Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
Stone S
Int J Fertil; 1992; 37(5):286-9. PubMed ID: 1358840
[No Abstract] [Full Text] [Related]
34. [Axillary vein thrombosis in a young woman with a contraceptive ring. Prothrombin gene mutation a possible connection].
Samuelsson E; Hultdin J; Groth K; Hedenmalm K
Lakartidningen; 2007 Jan 10-16; 104(1-2):32-4. PubMed ID: 17323737
[No Abstract] [Full Text] [Related]
35. Reciprocal coordination of a combination oral contraceptive containing desogestrel+ethinyl estradiol on the expression of LOX-1 and LDLR in placental trophoblast cells.
Pandey H; Arjuman A; Roy KK; Chandra NC
Contraception; 2011 Dec; 84(6):e43-9. PubMed ID: 22078205
[TBL] [Abstract][Full Text] [Related]
36. [Changes in the concentration of individual proteins in women using current peroral contraceptives].
Ulichkova E; Malinova M; Pekhlivanov B; Sirakova I
Akush Ginekol (Sofiia); 1999; 38(2):27-9. PubMed ID: 10730381
[TBL] [Abstract][Full Text] [Related]
37. Cerebral venous thrombosis as a complication of oral contraceptive use in a 15-year-old patient: a case report.
Hill LW; Hindelang FM
J La State Med Soc; 2007; 159(4):195, 197. PubMed ID: 17987956
[TBL] [Abstract][Full Text] [Related]
38. [Back up contraception].
Dacheva T
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
[No Abstract] [Full Text] [Related]
39. Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study.
Leone Roberti Maggiore U; Remorgida V; Scala C; Tafi E; Venturini PL; Ferrero S
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):239-47. PubMed ID: 24372517
[TBL] [Abstract][Full Text] [Related]
40. [Novynette--trends in contraception at the beginning of the new millennium].
Ivanov S; Sigridov I
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():30-2. PubMed ID: 15518273
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
